Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant Recipients

Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant Recipients

Background/Objectives: The efficacy of monovalent BNT162b2 Omicron XBB.1.5 booster vaccination in liver transplant recipients (LTRs) has yet to be described, particularly regarding the immune response to emerging variants like JN.1. Methods: This study evaluated humoral and cellular immune responses...

Full description

Bibliographic Details
Main Authors: Philippa von der Schulenburg, Georg M. N. Behrens, Markus Hoffmann, Alexandra Linke, Inga Nehlmeier, Amy Madeleine Kempf, Metodi Stankov, Marc Lütgehetmann, Jacqueline Jahnke-Triankowski, Marylyn M. Addo, Lutz Fischer, Ansgar W. Lohse, Stefan Pöhlmann, Julian Schulze zur Wiesch, Martina Sterneck
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Viruses
Subjects:
SARS-CoV-2
vaccination
COVID-19
liver transplantation
XBB.1.5
JN.1
Online Access:https://www.mdpi.com/1999-4915/16/12/1942

Internet

https://www.mdpi.com/1999-4915/16/12/1942

Similar Items